dipyridamole has been researched along with Nervous System Diseases in 7 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Oral administration of ticlopidine inhibited the transient thrombocytopenia caused by ADP." | 3.66 | Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP. ( Butler, KD; White, AM, 1980) |
| "Hydrogen sulfide is an environmental toxicant and gaseous neurotransmitter." | 1.39 | Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis. ( Landisch, R; Prah, M; Quirk, B; Schmainda, K; Verma, S; Whelan, HT; Willoughby, RE, 2013) |
| "20 patients with thrombotic thrombocytopenic purpura (TTP) admitted to the Mt." | 1.26 | Thrombotic thrombocytopenic purpura: a ten-year experience. ( Cuttner, J, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verma, S | 1 |
| Landisch, R | 1 |
| Quirk, B | 1 |
| Schmainda, K | 1 |
| Prah, M | 1 |
| Whelan, HT | 1 |
| Willoughby, RE | 1 |
| Cuttner, J | 1 |
| Butler, KD | 1 |
| White, AM | 1 |
| Tomlin, P | 1 |
| Newton, R | 1 |
| Schechter, D | 1 |
| Bocher, M | 1 |
| Berlatzky, Y | 1 |
| Anner, H | 1 |
| Argov, Z | 1 |
| Beer, G | 1 |
| Krausz, Y | 1 |
| Gotsman, MS | 1 |
| Chisin, R | 1 |
| Preston, FE | 1 |
| Martin, JF | 1 |
| Stewart, RM | 1 |
| Davies-Jones, GA | 1 |
| Jiménez-Castellanos, J | 1 |
| Ramos, JL | 1 |
| Murga, M | 1 |
| Mármol, D | 1 |
7 other studies available for dipyridamole and Nervous System Diseases
| Article | Year |
|---|---|
Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis.
Topics: Brain; Child, Preschool; Cognition Disorders; Dipyridamole; Humans; Hydrogen Sulfide; Hyperbaric Oxy | 2013 |
Thrombotic thrombocytopenic purpura: a ten-year experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aspirin; Dextrans; Dipyridamole; Female; Heparin; | 1980 |
Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP.
Topics: Adenosine Diphosphate; Animals; Antibodies; Arthus Reaction; Aspirin; Dipyridamole; Forssman Antigen | 1980 |
Blood platelets and neurological dysfunction.
Topics: Aspirin; Blood Platelets; Child; Dipyridamole; Humans; Ischemic Attack, Transient; Migraine Disorder | 1982 |
Transient neurological events during dipyridamole stress test: an arterial steal phenomenon?
Topics: Aged; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Exercise; Hand Strength; Heart; Hum | 1994 |
Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelet Disorders; Child; Dipyridamole; Drug Therapy, Combi | 1979 |
[Clinical and experimental results with the use of Persantin in neurology].
Topics: Adolescent; Adult; Aged; Animals; Cerebrovascular Circulation; Dipyridamole; Dogs; Female; Humans; M | 1966 |